Gore胸支内植物在主动脉弓0-2区的真实世界结局及2区与TEVAR+LSAB比较
单中心回顾性研究纳入75例0-2区TBE患者,2区占66.7%。30天永久性脑卒中在0区为20%,1区心肌缺血为20%。1年总生存率80.4%,分支通畅率100%。2区TBE与TEVAR+LSAB相比,术后急性肾损伤和心肌缺血更低、住院更短、再干预更少。
要点
- TBE在0-2区真实世界中安全有效,中期并发症低。
- 2区TBE较TEVAR+LSAB并发症更少、住院更短、再干预率更低。
- 0区和1区仍需进一步比较研究。
核心结论
- TBE在真实世界中对0-2区修复安全有效,中期并发症低。
- 2区TBE较TEVAR+LSAB住院更短、并发症更少、再干预率更低,支持作为合适解剖的首选策略。
研究设计与样本
- 单中心回顾性连续病例 review,纳入75例0-2区TBE患者。
- 亚组比较2区TBE(n=50)与同中心2区TEVAR+LSAB(n=94),采用多因素回归和Cox比例风险模型校正干预类型、指征、紧急程度、既往主动脉手术、覆盖区数和近端装置直径。
主要发现
- 30天永久性脑卒中在0区为20%,心肌缺血在1区为20%,均显著高于其他区。
- 1年总生存率80.4%,IA型内漏1.3%,瘤囊回缩60%,假腔血栓形成100%,分支通畅100%。
关键数值与推荐
- 2区TBE较TEVAR+LSAB的心肌缺血OR 0.12(95%CI 0.01-0.98)。
临床怎么用
- 在合适解剖的2区主动脉弓病变中,可优先考虑TBE以降低并发症、缩短住院和减少再干预。
- 0区和1区TBE应用需警惕永久性脑卒中和心肌缺血风险。
局限性
- 单中心回顾性研究,样本量有限。
- 0区和1区缺乏与TEVAR+LSAB的对照比较。
- 需进一步比较研究评估0区和1区治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study reports real-world outcomes of zone 0 and 1 thoracic branch endoprosthesis (TBE) after US Food and Drug Administration approval and compares zone 2 TBE with thoracic endovascular aortic repair (TEVAR) with left subclavian artery bypass (LSAB). METHODS: We retrospectively reviewed consecutive patients undergoing zone 0 to 2 TBE at a single center. Additionally, we performed a sub-analysis comparison with zone 2 TEVAR + LSAB. Outcomes were assessed using multivariate regression and Cox proportional hazards models adjusting for intervention type, indication, urgency, prior aortic surgery, number of zones covered, and proximal device diameter. RESULTS: We included75 patients (median age, 69.5 years; 71.1% male) who underwent zone 0 to 2 TBE. Of these, 50 patients (66.7%) were performed for zone 2, 13.3% zone 1, and 20% zone 0, with 28% performed in an urgent/emergent fashion; 37.3% had prior ascending/arch repair and 13.3% prior TEVAR. Indications were 16% aneurysm, 66.7% dissection, and 17.3% penetrating aortic ulcer or intramural hematoma. Approximately one-half (51.4%) used the 12-mm portal configuration, and 48.6% used the 8-mm portal configuration. Proximal cuffs were needed in 14.7%. The 30-day outcomes showed a significantly higher incidence of permanent cerebrovascular accident in zone 0 (20%) and higher myocardial ischemia in zone 1 (20%) compared with the other zones. One-year outcomes showed an 80.4% overall survival rate, 1.3% type IA endoleak, 60% sac regression, 100% false lumen thrombosis at 1 year, and 100% branch patency. When focusing on the zone 2 TBE only (n = 50) and comparing on multivariate-adjusted outcomes with zone 2 TEVAR + LSAB performed at the same institution (n = 94), zone 2 TBE was associated with lower rates of postoperative acute kidney injury (odds ratio [OR], 0.23; 95% confidence interval [CI], 0.04-0.99; P = .048) and myocardial ischemia (OR, 0.12; 95% CI, 0.01-0.98), shorter length of stay (β -1.7 days; 95% CI, -2.4 to -1.1; P < .001), reduced procedure time (β-54 minutes; 95% CI, -71 to -38; P = .001) and less contrast use (β-42 mL; 95% CI, -61 to -23 mL; P < .001), and greater 1-year sac regression (OR, 7.48; 95% CI, 1.43-12.27; P = .02). Adjusted Cox analysis showed TBE had greater freedom from reintervention (hazard ratio, 0.26; 95% CI, 0.6-0.92; P = .015). CONCLUSIONS: TBE in the real world is safe and effective for zone 0 to 2 repairs with low mid-term morbidity. Compared with TEVAR + LSAB, zone 2 TBE in particular results in shorter hospitalizations, fewer complications, and lower reintervention rates, supporting its use as the preferred strategy in suitable anatomy. Further comparative studies are needed for zones 0 and 1 treatment.
引用
- Satam K, Fereydooni A, Liu BC, et al. Real-world outcomes of the Gore thoracic branch endoprosthesis in aortic arch zones 0 to 2, with a zone 2 comparison to thoracic endovascular aortic repair with carotid-subclavian bypass. J Vasc Surg. 2026. PMID: 41713712. doi:10.1016/j.jvs.2026.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。